CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NSCLC: A RETROSPECTIVE ANALYSIS OF THE IMPACT OF PERFORMANCE STATUS, CHARLSON COMORBIDITY INDEX, BODY MASS INDEX AND HEMOGLOBIN AND C-REACTIVE PROTEIN LEVELS ON OVERALL SURVIVAL

被引:0
|
作者
Takahashi, Tiago K. [1 ]
Barbosa, Caroline C. L. [1 ]
Hoff, Paulo M. [1 ]
Castro, Gilberto, Jr. [1 ]
机构
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
关键词
elderly patients; Chemotherapy; prognostic factors; Non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S581 / S581
页数:1
相关论文
共 50 条
  • [21] Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade
    Jain, Aditya
    Zhang, Shijia
    Shanley, Ryan M.
    Fujioka, Naomi
    Kratzke, Robert A.
    Patel, Manish R.
    Kulkarni, Amit A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (05) : 1225 - 1232
  • [22] Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade
    Aditya Jain
    Shijia Zhang
    Ryan M. Shanley
    Naomi Fujioka
    Robert A. Kratzke
    Manish R. Patel
    Amit A. Kulkarni
    Cancer Immunology, Immunotherapy, 2023, 72 : 1225 - 1232
  • [23] Association between C-reactive protein-albumin-lymphocyte index and overall survival in patients with esophageal cancer
    Jia, Pingping
    Shen, Fangqi
    Zhao, Qianqian
    Wu, Xiaoxiao
    Sun, Kai
    Wang, Xiaolin
    Xu, Guangzhong
    Xu, Hongxia
    Cong, Minghua
    Song, Chunhua
    Shi, Hanping
    CLINICAL NUTRITION, 2025, 45 : 212 - 222
  • [24] The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy.
    Choi, Younak
    Oh, Do-Youn
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Bang, Yung-Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
    N J Timpson
    B G Nordestgaard
    R M Harbord
    J Zacho
    T M Frayling
    A Tybjærg-Hansen
    G Davey Smith
    International Journal of Obesity, 2011, 35 : 300 - 308
  • [26] C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
    Timpson, N. J.
    Nordestgaard, B. G.
    Harbord, R. M.
    Zacho, J.
    Frayling, T. M.
    Tybjaerg-Hansen, A.
    Smith, G. Davey
    INTERNATIONAL JOURNAL OF OBESITY, 2011, 35 (02) : 300 - 308
  • [27] Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups
    Holm, J. B.
    Baggesen, E.
    Cronin-Fenton, D.
    Frystyk, J.
    Bruun, J. M.
    Christiansen, P.
    Borgquist, S.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Age Adjusted Charlson Comorbidity Index Strongly Influences Survival, Irrespective of Performance Status and Age, in Patients With Advanced Prostatic Cancer Treated With Enzalutamide
    Van Halteren, Hendrik Karel
    Vreugdenhil, Gerard
    ANTICANCER RESEARCH, 2019, 39 (02) : 863 - 866
  • [29] Impact of weight and body mass index on high-sensitivity C-reactive protein response to adalimumab in hidradenitis suppurativa patients
    Zouboulis, Christos
    Adams, David
    Chen, Ke
    Goldblum, Orin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB53 - AB53
  • [30] Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy
    Koh, Young W.
    Lee, Hyun W.
    MEDICINE, 2017, 96 (19)